Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Endocr Relat Cancer. 2016 Jul 18;23(9):739–746. doi: 10.1530/ERC-16-0246

Table 2.

Growth hormone (GH) evaluation in patients with CNC

Evaluation test for GH excess Patients with GH excess (n=46)*
Elevated GH levels after OGTT test 30 (65.3%)
Elevated IGF-1 levels 27 (58.7%)
Elevated GH levels after TRH test 10 (21.7%)
Elevated 24-hour GH levels 8 (17.4%)
*

21 patients had GH excess in two or more evaluation tests